Search by Drug Name or NDC

    NDC 64764-0250-50 Nesina 25 mg/1 Details

    Nesina 25 mg/1

    Nesina is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is ALOGLIPTIN BENZOATE.

    Product Information

    NDC 64764-0250
    Product ID 64764-250_c5487e88-84e3-41df-ab12-fd2140cc6ef2
    Associated GPIs 27550010100330
    GCN Sequence Number 070517
    GCN Sequence Number Description alogliptin benzoate TABLET 25 MG ORAL
    HIC3 C4J
    HIC3 Description ANTIHYPERGLYCEMIC, DPP-4 INHIBITORS
    GCN 34076
    HICL Sequence Number 039968
    HICL Sequence Number Description ALOGLIPTIN BENZOATE
    Brand/Generic Brand
    Proprietary Name Nesina
    Proprietary Name Suffix n/a
    Non-Proprietary Name alogliptin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name ALOGLIPTIN BENZOATE
    Labeler Name Takeda Pharmaceuticals America, Inc.
    Pharmaceutical Class Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022271
    Listing Certified Through 2024-12-31

    Package

    NDC 64764-0250-50 (64764025050)

    NDC Package Code 64764-250-50
    Billing NDC 64764025050
    Package 500 TABLET, FILM COATED in 1 BOTTLE (64764-250-50)
    Marketing Start Date 2013-01-25
    NDC Exclude Flag N
    Pricing Information N/A